{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:54:51Z","timestamp":1785459291429,"version":"3.56.0"},"reference-count":248,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02400-3","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:39:25Z","timestamp":1769668765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning models for drug-drug interaction prediction from computational discovery to clinical application"],"prefix":"10.1038","volume":"9","author":[{"given":"Yuqing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nini","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2400_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards, I. R. & Aronson, J. K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356, 1255\u20131259 (2000).","journal-title":"Lancet"},{"key":"2400_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(04)01528-1","volume":"5","author":"JH Beijnen","year":"2004","unstructured":"Beijnen, J. H. & Schellens, J. H. M. Drug interactions in oncology. Lancet Oncol. 5, 489\u2013496 (2004).","journal-title":"Lancet Oncol."},{"key":"2400_CR3","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/S1470-2045(13)70579-5","volume":"15","author":"RWF van Leeuwen","year":"2014","unstructured":"van Leeuwen, R. W. F. et al. Drug\u2013drug interactions with tyrosine-kinase inhibitors: a clinical perspective. Lancet Oncol. 15, e315\u2013e326 (2014).","journal-title":"Lancet Oncol."},{"key":"2400_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato, D. M. et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern. Med. 176, 473\u2013482 (2016).","journal-title":"JAMA Intern. Med."},{"key":"2400_CR5","doi-asserted-by":"crossref","unstructured":"Leape, L. L. et al. Systems analysis of adverse drug events. JAMA 274, 35\u201343 (1995).","DOI":"10.1001\/jama.1995.03530010049034"},{"key":"2400_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith, C. T., Borisy, A. A. & Stockwell, B. R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 4, 71\u201378 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/annonc\/mdv029","volume":"26","author":"RWF van Leeuwen","year":"2015","unstructured":"van Leeuwen, R. W. F. et al. Drug\u2013drug interactions in patients treated for cancer: a prospective study on clinical interventions. Ann. Oncol. 26, 992\u2013997 (2015).","journal-title":"Ann. Oncol."},{"key":"2400_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/pr.115.011411","volume":"68","author":"JT Backman","year":"2016","unstructured":"Backman, J. T. et al. Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol. Rev. 68, 168\u2013241 (2016).","journal-title":"Pharmacol. Rev."},{"key":"2400_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nrd1851","volume":"4","author":"LC Wienkers","year":"2005","unstructured":"Wienkers, L. C. & Heath, T. G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discov. 4, 825\u2013833 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharmthera.2009.10.011","volume":"125","author":"A Hisaka","year":"2010","unstructured":"Hisaka, A. et al. Prediction of pharmacokinetic drug\u2013drug interaction caused by changes in cytochrome P450 activity using in vivo information. Pharmacol. Ther. 125, 230\u2013248 (2010).","journal-title":"Pharmacol. Ther."},{"key":"2400_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrgastro.2016.24","volume":"13","author":"JA Langness","year":"2016","unstructured":"Langness, J. A. & Everson, G. T. Drug\u2013drug interactions in HCV treatment\u2014the good, the bad and the ugly. Nat. Rev. Gastroenterol. Hepatol. 13, 194\u2013195 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2400_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/bib\/bbz087","volume":"21","author":"T Zhang","year":"2020","unstructured":"Zhang, T., Leng, J. & Liu, Y. Deep learning for drug\u2013drug interaction extraction from the literature: a review. Brief. Bioinform. 21, 1609\u20131627 (2020).","journal-title":"Brief. Bioinform."},{"key":"2400_CR13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","volume":"289","author":"DN Juurlink","year":"2003","unstructured":"Juurlink, D. N. et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289, 1652\u20131658 (2003).","journal-title":"JAMA"},{"key":"2400_CR14","doi-asserted-by":"publisher","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti, N. P. et al. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra31 (2012).","journal-title":"Sci. Transl. Med."},{"key":"2400_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2013.01.006","volume":"34","author":"B Percha","year":"2013","unstructured":"Percha, B. & Altman, R. B. Informatics confronts drug\u2013drug interactions. Trends Pharmacol. Sci. 34, 178\u2013184 (2013).","journal-title":"Trends Pharmacol. Sci."},{"key":"2400_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.7326\/M22-0281","volume":"175","author":"C Marzolini","year":"2022","unstructured":"Marzolini, C. et al. Prescribing nirmatrelvir\u2013ritonavir: how to recognize and manage drug\u2013drug interactions. Ann. Intern. Med. 175, 744\u2013746 (2022).","journal-title":"Ann. Intern. Med."},{"key":"2400_CR17","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkaa1061","volume":"49","author":"K Gallo","year":"2021","unstructured":"Gallo, K. et al. PROMISCUOUS 2.0: a resource for drug-repositioning. Nucleic Acids Res. 49, D1373\u2013D1380 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.03.006","volume":"86","author":"N Ai","year":"2015","unstructured":"Ai, N., Fan, X. & Ekins, S. In silico methods for predicting drug\u2013drug interactions with cytochrome P-450s, transporters and beyond. Adv. Drug Deliv. Rev. 86, 46\u201360 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2400_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108810","volume":"179","author":"S Singh","year":"2024","unstructured":"Singh, S., Kaur, N. & Gehlot, A. Application of artificial intelligence in drug design: a review. Comput. Biol. Med. 179, 108810 (2024).","journal-title":"Comput. Biol. Med."},{"key":"2400_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/TNNLS.2020.2978386","volume":"32","author":"Z Wu","year":"2020","unstructured":"Wu, Z. et al. A comprehensive survey on graph neural networks. IEEE Trans. Neural Netw. Learn. Syst. 32, 4\u201324 (2020).","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"2400_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1126\/science.253.5025.1242","volume":"253","author":"AK Joshi","year":"1991","unstructured":"Joshi, A. K. Natural language processing. Science 253, 1242\u20131249 (1991).","journal-title":"Science"},{"key":"2400_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1124\/pharmrev.122.000715","volume":"75","author":"D Trajanov","year":"2023","unstructured":"Trajanov, D. et al. Review of natural language processing in pharmacology. Pharmacol. Rev. 75, 714\u2013738 (2023).","journal-title":"Pharmacol. Rev."},{"key":"2400_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.aaa8685","volume":"349","author":"J Hirschberg","year":"2015","unstructured":"Hirschberg, J. & Manning, C. D. Advances in natural language processing. Science 349, 261\u2013266 (2015).","journal-title":"Science"},{"key":"2400_CR24","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1109\/TNNLS.2021.3084827","volume":"33","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. A survey of convolutional neural networks: analysis, applications, and prospects. IEEE Trans. Neural Netw. Learn. Syst. 33, 6999\u20137019 (2021).","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"2400_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41573-025-01164-x","volume":"24","author":"Z Tanoli","year":"2025","unstructured":"Tanoli, Z. et al. Computational drug repurposing: approaches, evaluation of in silico resources and case studies. Nat. Rev. Drug Discov. 24, 1\u201322 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2021.10.022","volume":"27","author":"A Bess","year":"2022","unstructured":"Bess, A. et al. Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases. Drug Discov. today 27, 1099\u20131107 (2022).","journal-title":"Drug Discov. today"},{"key":"2400_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","volume":"19","author":"P Schneider","year":"2020","unstructured":"Schneider, P. et al. Rethinking drug design in the artificial intelligence era. Nat. Rev. drug Discov. 19, 353\u2013364 (2020).","journal-title":"Nat. Rev. drug Discov."},{"key":"2400_CR28","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","volume":"119","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Concepts of artificial intelligence for computer-assisted drug discovery. Chem. Rev. 119, 10520\u201310594 (2019).","journal-title":"Chem. Rev."},{"key":"2400_CR29","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1038\/d41586-018-05267-x","volume":"557","author":"N Fleming","year":"2018","unstructured":"Fleming, N. How artificial intelligence is changing drug discovery. Nature 557, S55\u2013S55 (2018).","journal-title":"Nature"},{"key":"2400_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae496","volume":"40","author":"A Schulman","year":"2024","unstructured":"Schulman, A. et al. Attention-based approach to predict drug\u2013target interactions across seven target superfamilies. Bioinformatics 40, btae496 (2024).","journal-title":"Bioinformatics"},{"key":"2400_CR31","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1097\/JS9.0000000000000564","volume":"109","author":"S Chakraborty","year":"2023","unstructured":"Chakraborty, S. et al. Artificial intelligence (AI) is paving the way for a critical role in drug discovery, drug design, and studying drug\u2013drug interactions\u2013correspondence. Int. J. Surg. 109, 3242\u20133244 (2023).","journal-title":"Int. J. Surg."},{"key":"2400_CR32","doi-asserted-by":"publisher","first-page":"D355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2010","unstructured":"Kanehisa, M. et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355\u2013D360 (2010).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/joim.13483","volume":"292","author":"S Eloranta","year":"2022","unstructured":"Eloranta, S. & Boman, M. Predictive models for clinical decision making: Deep dives in practical machine learning. J. Intern. Med. 292, 278\u2013295 (2022).","journal-title":"J. Intern. Med."},{"key":"2400_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-00447-2","volume":"12","author":"MA Thafar","year":"2020","unstructured":"Thafar, M. A. et al. DTiGEMS+: drug\u2013target interaction prediction using graph embedding, graph mining, and similarity-based techniques. J. Cheminform. 12, 1\u201317 (2020).","journal-title":"J. Cheminform."},{"key":"2400_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01883-5","volume":"19","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. rs1990622 variant associates with Alzheimer\u2019s disease and regulates TMEM106B expression in human brain tissues. BMC Med. 19, 1\u201310 (2021).","journal-title":"BMC Med."},{"key":"2400_CR36","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/nprot.2014.151","volume":"9","author":"S Vilar","year":"2014","unstructured":"Vilar, S. et al. Similarity-based modeling in large-scale prediction of drug-drug interactions. Nat. Protoc. 9, 2147\u20132163 (2014).","journal-title":"Nat. Protoc."},{"key":"2400_CR37","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1007\/s10462-023-10484-6","volume":"56","author":"V Moscato","year":"2023","unstructured":"Moscato, V. et al. Multi-task learning for few-shot biomedical relation extraction. Artif. Intell. Rev. 56, 13743\u201313763 (2023).","journal-title":"Artif. Intell. Rev."},{"key":"2400_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ins.2019.05.017","volume":"497","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. SFLLN: a sparse feature learning ensemble method with linear neighborhood regularization for predicting drug\u2013drug interactions. Inf. Sci. 497, 189\u2013201 (2019).","journal-title":"Inf. Sci."},{"key":"2400_CR39","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1109\/JBHI.2020.3048059","volume":"25","author":"J Zhu","year":"2020","unstructured":"Zhu, J. et al. Attribute supervised probabilistic dependent matrix tri-factorization model for the prediction of adverse drug-drug interaction. IEEE J. Biomed. Health Inform. 25, 2820\u20132832 (2020).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2400_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1145\/3065386","volume":"60","author":"A Krizhevsky","year":"2017","unstructured":"Krizhevsky, A., Sutskever, I. & Hinton, G. E. ImageNet classification with deep convolutional neural networks. Commun. ACM 60, 84\u201390 (2017).","journal-title":"Commun. ACM"},{"key":"2400_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00639-0","volume":"5","author":"HY Jang","year":"2022","unstructured":"Jang, H. Y. et al. Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. NPJ Digit. Med. 5, 88 (2022).","journal-title":"NPJ Digit. Med."},{"key":"2400_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/msb.2012.26","volume":"8","author":"A Gottlieb","year":"2012","unstructured":"Gottlieb, A. et al. INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol. 8, 592 (2012).","journal-title":"Mol. Syst. Biol."},{"key":"2400_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1568","volume":"12","author":"M Staszak","year":"2022","unstructured":"Staszak, M. et al. Machine learning in drug design: use of artificial intelligence to explore the chemical structure\u2013biological activity relationship. Wiley Interdiscip. Rev. Comput. Mol. Sci. 12, e1568 (2022).","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"2400_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109496","volume":"185","author":"S Jung","year":"2025","unstructured":"Jung, S. & Yoo, S. Interpretable prediction of drug-drug interactions via text embedding in biomedical literature. Comput. Biol. Med. 185, 109496 (2025).","journal-title":"Comput. Biol. Med."},{"key":"2400_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/acs.jcim.3c01304","volume":"64","author":"NN Wang","year":"2023","unstructured":"Wang, N. N. et al. Comprehensive review of drug\u2013drug interaction prediction based on machine learning: current status, challenges, and opportunities. J. Chem. Inf. Model. 64, 96\u2013109 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"2400_CR46","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 52, D1265\u2013D1275 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR47","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091\u2013D1097 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR48","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901\u2013D906 (2008).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR49","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR50","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373\u2013D1380 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR51","doi-asserted-by":"publisher","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. PubChem\u2019s BioAssay database. Nucleic Acids Res. 40, D400\u2013D412 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR52","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim, S. et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 49, D1388\u2013D1395 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR53","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR55","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep12339","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang, P. et al. Label propagation prediction of drug-drug interactions based on clinical side effects. Sci. Rep. 5, 12339 (2015).","journal-title":"Sci. Rep."},{"key":"2400_CR57","doi-asserted-by":"publisher","first-page":"D1200","DOI":"10.1093\/nar\/gkab880","volume":"50","author":"G Xiong","year":"2022","unstructured":"Xiong, G. et al. DDInter: an online drug\u2013drug interaction database towards improving clinical decision-making and patient safety. Nucleic Acids Res. 50, D1200\u2013D1207 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR58","doi-asserted-by":"publisher","first-page":"D1356","DOI":"10.1093\/nar\/gkae726","volume":"53","author":"Y Tian","year":"2025","unstructured":"Tian, Y. et al. DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface. Nucleic Acids Res. 53, D1356\u2013D1362 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR59","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/clpt.2011.351","volume":"91","author":"K Yoshida","year":"2012","unstructured":"Yoshida, K., Maeda, K. & Sugiyama, Y. Transporter-mediated drug\u2013drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clin. Pharmacol. Ther. 91, 1053\u20131064 (2012).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR60","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bib\/bbx010","volume":"19","author":"S Vilar","year":"2018","unstructured":"Vilar, S., Friedman, C. & Hripcsak, G. Detection of drug\u2013drug interactions through data mining studies using clinical sources, scientific literature and social media. Brief. Bioinform. 19, 863\u2013877 (2018).","journal-title":"Brief. Bioinform."},{"key":"2400_CR61","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cpt.1547","volume":"106","author":"F Huth","year":"2019","unstructured":"Huth, F. et al. Prediction of the impact of CYP2C9 genotypes on the drug-drug interaction potential of siponimod with PBPK modeling: a comprehensive approach for drug label recommendations. Clin. Pharmacol. Ther. 106, 1113\u20131124 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR62","doi-asserted-by":"crossref","unstructured":"Wu H. Y., Chiang C. W. & Li L. Text mining for drug\u2013drug interaction. Biomed. Lit. Min. 1159, 47-75 (2014).","DOI":"10.1007\/978-1-4939-0709-0_4"},{"key":"2400_CR63","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic acids Res."},{"key":"2400_CR64","doi-asserted-by":"crossref","unstructured":"Kumari, A., Akhtar, M., Shah, R. & Tanveer, M. Support matrix machine: a review. Neural Netw. 181, 106767 (2025).","DOI":"10.1016\/j.neunet.2024.106767"},{"key":"2400_CR65","doi-asserted-by":"crossref","unstructured":"Suthaharan, S. Support vector machine. Machine Learning Models and Algorithms for Big Data Classification: Thinking with Examples for Effective Learning 207\u2013235 (Springer US, 2016).","DOI":"10.1007\/978-1-4899-7641-3_9"},{"key":"2400_CR66","doi-asserted-by":"crossref","unstructured":"Liu Y., Wang Y. & Zhang J. New machine learning algorithm: Random forest. International Conference on Information Computing And Applications 246\u2013252 (Springer Berlin Heidelberg, Berlin, Heidelberg, 2012).","DOI":"10.1007\/978-3-642-34062-8_32"},{"key":"2400_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neucom.2018.09.038","volume":"323","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Recent advances in convolutional neural network acceleration. Neurocomputing 323, 37\u201351 (2019).","journal-title":"Neurocomputing"},{"key":"2400_CR68","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1109\/JPROC.2021.3055400","volume":"109","author":"L Ruiz","year":"2021","unstructured":"Ruiz, L., Gama, F. & Ribeiro, A. Graph neural networks: architectures, stability, and transferability. Proc. IEEE 109, 660\u2013682 (2021).","journal-title":"Proc. IEEE"},{"key":"2400_CR69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bja.2019.10.017","volume":"124","author":"CV Cosgriff","year":"2020","unstructured":"Cosgriff, C. V. & Celi, L. A. Deep learning for risk assessment: all about automatic feature extraction. Br. J. Anaesth. 124, 131\u2013133 (2020).","journal-title":"Br. J. Anaesth."},{"key":"2400_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae604","volume":"40","author":"X Li","year":"2024","unstructured":"Li, X. et al. Dual-view jointly learning improves personalized drug synergy prediction. Bioinformatics 40, btae604 (2024).","journal-title":"Bioinformatics"},{"key":"2400_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad235","volume":"24","author":"X Lin","year":"2023","unstructured":"Lin, X. et al. Comprehensive evaluation of deep and graph learning on drug\u2013drug interactions prediction. Brief. Bioinform. 24, bbad235 (2023).","journal-title":"Brief. Bioinform."},{"key":"2400_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59431-9","volume":"16","author":"Z Ren","year":"2025","unstructured":"Ren, Z. et al. Predicting rare drug-drug interaction events with dual-granular structure-adaptive and pair variational representation. Nat. Commun. 16, 3997 (2025).","journal-title":"Nat. Commun."},{"key":"2400_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2025.104772","volume":"162","author":"S Gao","year":"2025","unstructured":"Gao, S., Xie, J. & Zhao, Y. A multi-source drug combination and omnidirectional feature fusion approach for predicting drug-drug interaction events. J. Biomed. Inform. 162, 104772 (2025).","journal-title":"J. Biomed. Inform."},{"key":"2400_CR74","doi-asserted-by":"crossref","unstructured":"Bai, C. et al. Machine learning-enabled drug-induced toxicity prediction. Adv. Sci. 12, 2413405 (2025).","DOI":"10.1002\/advs.202413405"},{"key":"2400_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411325","volume":"12","author":"Z Wan","year":"2025","unstructured":"Wan, Z. et al. Applications of artificial intelligence in drug repurposing. Adv. Sci. 12, 2411325 (2025).","journal-title":"Adv. Sci."},{"key":"2400_CR76","doi-asserted-by":"crossref","unstructured":"Deng, H. et al. MTMG: a multi-task model with multi-granularity information for drug-drug interaction extraction. Heliyon 9, e16819 (2023).","DOI":"10.1016\/j.heliyon.2023.e16819"},{"key":"2400_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2022.119312","volume":"215","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. DAEM: Deep attributed embedding based multi-task learning for predicting adverse drug\u2013drug interaction. Expert Syst. Appl. 215, 119312 (2023).","journal-title":"Expert Syst. Appl."},{"key":"2400_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/bdcc6010030","volume":"6","author":"M Salman","year":"2022","unstructured":"Salman, M. et al. Big data management in drug\u2013drug interaction: a modern deep learning approach for smart healthcare. Big Data Cogn. Comput. 6, 30 (2022).","journal-title":"Big Data Cogn. Comput."},{"key":"2400_CR79","volume":"22","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Drug\u2013drug similarity measure and its applications. Brief. Bioinform. 22, bbaa265 (2021).","journal-title":"Brief. Bioinform."},{"key":"2400_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-017-0200-8","volume":"9","author":"T Takeda","year":"2017","unstructured":"Takeda, T. et al. Predicting drug\u2013drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge. J. Cheminform. 9, 1\u20139 (2017).","journal-title":"J. Cheminform."},{"key":"2400_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jbi.2015.03.002","volume":"55","author":"S Kim","year":"2015","unstructured":"Kim, S. et al. Extracting drug\u2013drug interactions from literature using a rich feature-based linear kernel approach. J. Biomed. Inform. 55, 23\u201330 (2015).","journal-title":"J. Biomed. Inform."},{"key":"2400_CR82","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1093\/bioinformatics\/btu557","volume":"30","author":"QC Bui","year":"2014","unstructured":"Bui, Q. C. et al. A novel feature-based approach to extract drug\u2013drug interactions from biomedical text. Bioinformatics 30, 3365\u20133371 (2014).","journal-title":"Bioinformatics"},{"key":"2400_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.artmed.2018.03.001","volume":"87","author":"D Zhou","year":"2018","unstructured":"Zhou, D., Miao, L. & He, Y. Position-aware deep multi-task learning for drug\u2013drug interaction extraction. Artif. Intell. Med. 87, 1\u20138 (2018).","journal-title":"Artif. Intell. Med."},{"key":"2400_CR84","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/molecules28020844","volume":"28","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. DEML: drug synergy and interaction prediction using ensemble-based multi-task learning. Molecules 28, 844 (2023).","journal-title":"Molecules"},{"key":"2400_CR85","doi-asserted-by":"publisher","first-page":"v350","DOI":"10.1093\/annonc\/mdz248.047","volume":"30","author":"CR Zurth","year":"2019","unstructured":"Zurth, C. R. et al. Assessing the clinical relevance of drug-drug interactions (DDI) with darolutamide (DARO). Ann. Oncol. 30, v350 (2019).","journal-title":"Ann. Oncol."},{"key":"2400_CR86","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1093\/annonc\/mdq149","volume":"21","author":"MS Aapro","year":"2010","unstructured":"Aapro, M. S. & Walko, C. M. Aprepitant: drug\u2013drug interactions in perspective. Ann. Oncol. 21, 2316\u20132323 (2010).","journal-title":"Ann. Oncol."},{"key":"2400_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30189-z","volume":"8","author":"JY Shi","year":"2018","unstructured":"Shi, J. Y. et al. An integrated local classification model of predicting drug-drug interactions via Dempster-Shafer theory of evidence. Sci. Rep. 8, 11829 (2018).","journal-title":"Sci. Rep."},{"key":"2400_CR88","doi-asserted-by":"publisher","first-page":"e0196865","DOI":"10.1371\/journal.pone.0196865","volume":"13","author":"A Kastrin","year":"2018","unstructured":"Kastrin, A., Ferk, P. & Lesko\u0161ek, B. Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning. PLoS ONE 13, e0196865 (2018).","journal-title":"PLoS ONE"},{"key":"2400_CR89","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1136\/amiajnl-2013-002512","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng, F. & Zhao, Z. Machine learning-based prediction of drug\u2013drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J. Am. Med. Inform. Assoc. 21, e278\u2013e286 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"2400_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.794205","volume":"12","author":"XY Yan","year":"2021","unstructured":"Yan, X. Y. et al. Prediction of the drug\u2013drug interaction types with the unified embedding features from drug similarity networks. Front. Pharmacol. 12, 794205 (2021).","journal-title":"Front. Pharmacol."},{"key":"2400_CR91","volume":"15","author":"PL Mar","year":"2022","unstructured":"Mar, P. L. et al. Drug interactions affecting oral anticoagulant use. Circ. Arrhythm. Electrophysiol. 15, e007956 (2022).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"2400_CR92","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jcpt.12786","volume":"44","author":"D Song","year":"2019","unstructured":"Song, D. et al. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies. J. Clin. Pharm. Ther. 44, 268\u2013275 (2019).","journal-title":"J. Clin. Pharm. Ther."},{"key":"2400_CR93","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/bioinformatics\/btw342","volume":"32","author":"D Sridhar","year":"2016","unstructured":"Sridhar, D., Fakhraei, S. & Getoor, L. A probabilistic approach for collective similarity-based drug\u2013drug interaction prediction. Bioinformatics 32, 3175\u20133182 (2016).","journal-title":"Bioinformatics"},{"key":"2400_CR94","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1109\/TCBB.2020.2988018","volume":"19","author":"C Yan","year":"2020","unstructured":"Yan, C. et al. Predicting drug-drug interactions based on integrated similarity and semi-supervised learning. IEEE\/ACM Trans. Comput. Biol. Bioinform. 19, 168\u2013179 (2020).","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"2400_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad539","volume":"25","author":"YH Yang","year":"2024","unstructured":"Yang, Y. H., Yang, J. T. & Liu, J. F. Lactylation prediction models based on protein sequence and structural feature fusion. Brief. Bioinform. 25, bbad539 (2024).","journal-title":"Brief. Bioinform."},{"key":"2400_CR96","doi-asserted-by":"publisher","first-page":"10750","DOI":"10.3390\/app131910750","volume":"13","author":"Y Liang","year":"2023","unstructured":"Liang, Y. DDI-SSL: drug\u2013drug interaction prediction based on substructure signature learning. Appl. Sci. 13, 10750 (2023).","journal-title":"Appl. Sci."},{"key":"2400_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab133","volume":"22","author":"AK Nyamabo","year":"2021","unstructured":"Nyamabo, A. K., Yu, H. & Shi, J. Y. SSI\u2013DDI: substructure\u2013substructure interactions for drug\u2013drug interaction prediction. Brief. Bioinform. 22, bbab133 (2021).","journal-title":"Brief. Bioinform."},{"key":"2400_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12539-023-00550-6","volume":"15","author":"L Guo","year":"2023","unstructured":"Guo, L. et al. MSResG: using GAE and residual GCN to predict drug\u2013drug interactions based on multi-source drug features. J. Interdiscip. Sci. Comput. Life Sci. 15, 171\u2013188 (2023).","journal-title":"J. Interdiscip. Sci. Comput. Life Sci."},{"key":"2400_CR99","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.3390\/molecules29204829","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang, J., Wang, X. & Pang, Y. StructNet-DDI: molecular structure characterization-based ResNet for prediction of drug\u2013drug interactions. Molecules 29, 4829 (2024).","journal-title":"Molecules"},{"key":"2400_CR100","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/bib\/bbz153","volume":"22","author":"B G\u00fcven\u00e7 Paltun","year":"2021","unstructured":"G\u00fcven\u00e7 Paltun, B., Mamitsuka, H. & Kaski, S. Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches. Brief. Bioinforma. 22, 346\u2013359 (2021).","journal-title":"Brief. Bioinforma."},{"key":"2400_CR101","doi-asserted-by":"crossref","unstructured":"Liu, Q. et al. Leveraging network target theory for efficient prediction of drug-disease interactions: a transfer learning approach. Adv. Sci. 12, 2409130 (2025).","DOI":"10.1002\/advs.202409130"},{"key":"2400_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00442-z","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang, W. et al. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Min. 18, 27 (2025).","journal-title":"BioData Min."},{"key":"2400_CR103","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/bib\/bbaa012","volume":"22","author":"SK Mohamed","year":"2021","unstructured":"Mohamed, S. K., Nounu, A. & Nov\u00e1\u010dek, V. Biological applications of knowledge graph embedding models. Brief. Bioinforma. 22, 1679\u20131693 (2021).","journal-title":"Brief. Bioinforma."},{"key":"2400_CR104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1109\/RBME.2021.3122522","volume":"16","author":"R Li","year":"2021","unstructured":"Li, R. et al. Graph signal processing, graph neural network and graph learning on biological data: a systematic review. IEEE Rev. Biomed. Eng. 16, 109\u2013135 (2021).","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"2400_CR105","doi-asserted-by":"crossref","unstructured":"Zhang Y., Mastouri M. & Zhang Y. Accelerating drug discovery, development, and clinical trials by artificial intelligence. Med 5, 1050\u20131070 (2024).","DOI":"10.1016\/j.medj.2024.07.026"},{"key":"2400_CR106","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","volume":"23","author":"S Honap","year":"2024","unstructured":"Honap, S. et al. Navigating the complexities of drug development for inflammatory bowel disease. Nat. Rev. Drug Discov. 23, 546\u2013562 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR107","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1208\/s12248-013-9470-x","volume":"15","author":"T Prueksaritanont","year":"2013","unstructured":"Prueksaritanont, T. et al. Drug\u2013drug interaction studies: regulatory guidance and an industry perspective. AAPS J. 15, 629\u2013645 (2013).","journal-title":"AAPS J."},{"key":"2400_CR108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1137\/1035134","volume":"35","author":"GW Stewart","year":"1993","unstructured":"Stewart, G. W. On the early history of the singular value decomposition. SIAM Rev. 35, 551\u2013566 (1993).","journal-title":"SIAM Rev."},{"key":"2400_CR109","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/44565","volume":"401","author":"DD Lee","year":"1999","unstructured":"Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. nature 401, 788\u2013791 (1999).","journal-title":"nature"},{"key":"2400_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-019-0352-9","volume":"11","author":"JY Shi","year":"2019","unstructured":"Shi, J. Y. et al. Detecting drug communities and predicting comprehensive drug\u2013drug interactions via balance regularized semi-nonnegative matrix factorization. J. Cheminform. 11, 1\u201316 (2019).","journal-title":"J. Cheminform."},{"key":"2400_CR111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jbi.2018.11.005","volume":"88","author":"W Zhang","year":"2018","unstructured":"Zhang, W. et al. Manifold regularized matrix factorization for drug-drug interaction prediction. J. Biomed. Inform. 88, 90\u201397 (2018).","journal-title":"J. Biomed. Inform."},{"key":"2400_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13721-019-0215-3","volume":"9","author":"N Rohani","year":"2020","unstructured":"Rohani, N., Eslahchi, C. & Katanforoush, A. ISCMF: integrated similarity-constrained matrix factorization for drug\u2013drug interaction prediction. Netw. Model. Anal. Health Inform. Bioinform. 9, 1\u20138 (2020).","journal-title":"Netw. Model. Anal. Health Inform. Bioinform."},{"key":"2400_CR113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12859-018-2379-8","volume":"19","author":"JY Shi","year":"2018","unstructured":"Shi, J. Y. et al. TMFUF: a triple matrix factorization-based unified framework for predicting comprehensive drug-drug interactions of new drugs. BMC Bioinform. 19, 27\u201337 (2018).","journal-title":"BMC Bioinform."},{"key":"2400_CR114","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1109\/JBHI.2023.3246225","volume":"27","author":"S Jain","year":"2023","unstructured":"Jain, S. et al. Graph regularized probabilistic matrix factorization for drug-drug interactions prediction. IEEE J. Biomed. Health Inform. 27, 2565\u20132574 (2023).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2400_CR115","doi-asserted-by":"crossref","unstructured":"Tang J. et al. Line: large-scale information network embedding. In Proc. 24th International Conference On World Wide Web 1067\u20131077 (2015).","DOI":"10.1145\/2736277.2741093"},{"key":"2400_CR116","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa256","volume":"22","author":"Y Dai","year":"2021","unstructured":"Dai, Y. et al. Drug\u2013drug interaction prediction with Wasserstein Adversarial Autoencoder-based knowledge graph embeddings. Brief. Bioinforma. 22, bbaa256 (2021).","journal-title":"Brief. Bioinforma."},{"key":"2400_CR117","doi-asserted-by":"publisher","first-page":"e28277","DOI":"10.2196\/28277","volume":"9","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Drug-drug interaction predictions via knowledge graph and text embedding: instrument validation study. JMIR Med. Inform. 9, e28277 (2021).","journal-title":"JMIR Med. Inform."},{"key":"2400_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucom.2023.127203","volume":"572","author":"M Jiang","year":"2024","unstructured":"Jiang, M. et al. Relation-aware graph structure embedding with co-contrastive learning for drug\u2013drug interaction prediction. Neurocomputing 572, 127203 (2024).","journal-title":"Neurocomputing"},{"key":"2400_CR119","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa243","volume":"22","author":"Z Yu","year":"2021","unstructured":"Yu, Z. et al. Predicting drug\u2013disease associations through layer attention graph convolutional network. Brief. Bioinforma. 22, bbaa243 (2021).","journal-title":"Brief. Bioinforma."},{"key":"2400_CR120","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/life12020319","volume":"12","author":"X Han","year":"2022","unstructured":"Han, X. et al. Smilegnn: drug\u2013drug interaction prediction based on the smiles and graph neural network. Life 12, 319 (2022).","journal-title":"Life"},{"key":"2400_CR121","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad155","volume":"24","author":"H Yu","year":"2023","unstructured":"Yu, H. et al. Attention-based cross domain graph neural network for prediction of drug\u2013drug interactions. Brief. Bioinforma. 24, bbad155 (2023).","journal-title":"Brief. Bioinforma."},{"key":"2400_CR122","unstructured":"Peng, L. et al. Reverse graph learning for graph neural network. In IEEE Transactions on Neural Networks and Learning Systems (2022)."},{"key":"2400_CR123","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/cmb.2022.0113","volume":"29","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. SGFNNs: signed graph filtering-based neural networks for predicting drug\u2013drug interactions. J. Comput. Biol. 29, 1104\u20131116 (2022).","journal-title":"J. Comput. Biol."},{"key":"2400_CR124","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1109\/JBHI.2024.3349570","volume":"28","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. Autoddi: drug\u2013drug interaction prediction with automated graph neural network. IEEE J. Biomed. Health Inform. 28, 1773\u20131784 (2024).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2400_CR125","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Attention is all you need: utilizing attention in AI-enabled drug discovery. Brief. Bioinform. 25, bbad467 (2024).","DOI":"10.1093\/bib\/bbad467"},{"key":"2400_CR126","doi-asserted-by":"publisher","DOI":"10.1007\/s13755-023-00250-x","volume":"11","author":"L Huang","year":"2023","unstructured":"Huang, L., Chen, Q. & Lan, W. Predicting drug\u2013drug interactions based on multi-view and multichannel attention deep learning. Health Inf. Sci. Syst. 11, 50 (2023).","journal-title":"Health Inf. Sci. Syst."},{"key":"2400_CR127","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab421","volume":"23","author":"S Lin","year":"2022","unstructured":"Lin, S. et al. MDF-SA-DDI: predicting drug\u2013drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism. Brief. Bioinform. 23, bbab421 (2022).","journal-title":"Brief. Bioinform."},{"key":"2400_CR128","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.patcog.2016.03.028","volume":"58","author":"SM Erfani","year":"2016","unstructured":"Erfani, S. M. et al. High-dimensional and large-scale anomaly detection using a linear one-class SVM with deep learning. Pattern Recognit. 58, 121\u2013134 (2016).","journal-title":"Pattern Recognit."},{"key":"2400_CR129","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/JBHI.2016.2636665","volume":"21","author":"D Rav\u00ec","year":"2016","unstructured":"Rav\u00ec, D. et al. Deep learning for health informatics. IEEE J. Biomed. Health Inform. 21, 4\u201321 (2016).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2400_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05242-y","volume":"24","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. CNN-Siam: multimodal siamese CNN-based deep learning approach for drug\u2012drug interaction prediction. BMC Bioinform. 24, 110 (2023).","journal-title":"BMC Bioinform."},{"key":"2400_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1458739","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Large language models facilitating modern molecular biology and novel drug development. Front. Pharmacol. 15, 1458739 (2024).","journal-title":"Front. Pharmacol."},{"key":"2400_CR132","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1016\/j.csbj.2024.09.031","volume":"23","author":"OA Sarumi","year":"2024","unstructured":"Sarumi, O. A. & Heider, D. Large language models and their applications in bioinformatics. Comput. Struct. Biotechnol. J. 23, 3498\u20133505 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2400_CR133","doi-asserted-by":"crossref","unstructured":"Yuan, S. et al. Enhancing herbal medicine-drug interaction prediction using large language models. IEEE Journal of Biomedical and Health Informatics (2025).","DOI":"10.1109\/JBHI.2025.3558667"},{"key":"2400_CR134","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/17460441.2025.2490835","volume":"20","author":"CA Withers","year":"2025","unstructured":"Withers, C. A. et al. Natural language processing in drug discovery: bridging the gap between text and therapeutics with artificial intelligence. Expert Opin. Drug Discov. 20, 765\u2013783 (2025).","journal-title":"Expert Opin. Drug Discov."},{"key":"2400_CR135","doi-asserted-by":"crossref","unstructured":"Li, D. et al. LLM-DDI: leveraging large language models for drug-drug interaction prediction on biomedical knowledge graph. IEEE Journal of Biomedical and Health Informatics (2025).","DOI":"10.1109\/JBHI.2025.3585290"},{"key":"2400_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1589788","volume":"16","author":"H Qi","year":"2025","unstructured":"Qi, H. et al. Improving drug-drug interaction prediction via in-context learning and judging with large language models. Front. Pharmacol. 16, 1589788 (2025).","journal-title":"Front. Pharmacol."},{"key":"2400_CR137","unstructured":"Kumar, P. Diffusion Models and Generative Artificial Intelligence: Frameworks, Applications and Challenges. Archives of Computational Methods in Engineering, 1\u201344 (2025)."},{"key":"2400_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3554729","volume":"56","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Diffusion models: a comprehensive survey of methods and applications. ACM Comput. Surv. 56, 1\u201339 (2023).","journal-title":"ACM Comput. Surv."},{"key":"2400_CR139","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s42256-024-00911-w","volume":"6","author":"C Wognum","year":"2024","unstructured":"Wognum, C. et al. A call for an industry-led initiative to critically assess machine learning for real-world drug discovery. Nat. Mach. Intell. 6, 1120\u20131121 (2024).","journal-title":"Nat. Mach. Intell."},{"key":"2400_CR140","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s42254-022-00441-7","volume":"4","author":"J Thiyagalingam","year":"2022","unstructured":"Thiyagalingam, J. et al. Scientific machine learning benchmarks. Nat. Rev. Phys. 4, 413\u2013420 (2022).","journal-title":"Nat. Rev. Phys."},{"key":"2400_CR141","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00228-008-0612-5","volume":"65","author":"Y B\u00f6ttiger","year":"2009","unstructured":"B\u00f6ttiger, Y. et al. SFINX-a drug-drug interaction database designed for clinical decision support systems. Eur. J. Clin. Pharmacol. 65, 627\u2013633 (2009).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2400_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie, B. et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995\u20132010. BMC Med. 13, 74 (2015).","journal-title":"BMC Med."},{"key":"2400_CR143","doi-asserted-by":"crossref","unstructured":"Altalhan M., Algarni A. & Alouane M. T. H. Imbalanced data problem in machine learning: a review. IEEE Access, (2025).","DOI":"10.1109\/ACCESS.2025.3531662"},{"key":"2400_CR144","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.procs.2019.11.146","volume":"161","author":"S Gupta","year":"2019","unstructured":"Gupta, S. & Gupta, A. Dealing with noise problem in machine learning data-sets: a systematic review. Procedia Comput. Sci. 161, 466\u2013474 (2019).","journal-title":"Procedia Comput. Sci."},{"key":"2400_CR145","first-page":"1","volume":"52","author":"H Kaur","year":"2019","unstructured":"Kaur, H., Pannu, H. S. & Malhi, A. K. A systematic review on imbalanced data challenges in machine learning: applications and solutions. J. ACM Comput. Surv. (CSUR) 52, 1\u201336 (2019).","journal-title":"J. ACM Comput. Surv. (CSUR)"},{"key":"2400_CR146","doi-asserted-by":"crossref","unstructured":"Xie W. et al. Extracting Drug-Drug Interactions from Biomedical Texts Using BioBERT with Improved Focal Loss. In Proc. 11th International Conference on Bioinformatics and Computational Biology (ICBCB) 99\u2013104 (IEEE, 2023).","DOI":"10.1109\/ICBCB57893.2023.10246572"},{"key":"2400_CR147","doi-asserted-by":"crossref","unstructured":"Li, J., Xiong, C. & Hoi, S. C. H. Learning from noisy data with robust representation learning. In Proc. IEEE\/CVF International Conference on Computer Vision 9485\u20139494 (2021).","DOI":"10.1109\/ICCV48922.2021.00935"},{"key":"2400_CR148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10462-024-10759-6","volume":"57","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. A survey on imbalanced learning: latest research, applications and future directions. Artif. Intell. Rev. 57, 137 (2024).","journal-title":"Artif. Intell. Rev."},{"key":"2400_CR149","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jhep.2012.10.027","volume":"58","author":"D Burger","year":"2013","unstructured":"Burger, D. et al. Clinical management of drug\u2013drug interactions in HCV therapy: challenges and solutions. J. Hepatol. 58, 792\u2013800 (2013).","journal-title":"J. Hepatol."},{"key":"2400_CR150","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","volume":"106","author":"TKL Kiang","year":"2005","unstructured":"Kiang, T. K. L., Ensom, M. H. H. & Chang, T. K. H. UDP-glucuronosyltransferases and clinical drug-drug interactions. J. Pharmacol. Ther. 106, 97\u2013132 (2005).","journal-title":"J. Pharmacol. Ther."},{"key":"2400_CR151","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia, J. et al. Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111\u2013128 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR152","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/bib\/bby004","volume":"20","author":"IF Tsigelny","year":"2019","unstructured":"Tsigelny, I. F. Artificial intelligence in drug combination therapy. Brief. Bioinform. 20, 1434\u20131448 (2019).","journal-title":"Brief. Bioinform."},{"key":"2400_CR153","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac427","volume":"23","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Artificial intelligence-driven prediction of multiple drug interactions. Brief. Bioinform. 23, bbac427 (2022).","journal-title":"Brief. Bioinform."},{"key":"2400_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3645089","volume":"56","author":"M Dou","year":"2024","unstructured":"Dou, M. et al. Drug\u2013drug interaction relation extraction based on deep learning: a review. ACM Comput. Surv. 56, 1\u201333 (2024).","journal-title":"ACM Comput. Surv."},{"key":"2400_CR155","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jcmg.2017.07.024","volume":"11","author":"J Betancur","year":"2018","unstructured":"Betancur, J. et al. Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning. JACC Cardiovasc. Imaging 11, 1000\u20131009 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"2400_CR156","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","volume":"55","author":"S Dara","year":"2022","unstructured":"Dara, S. et al. Machine learning in drug discovery: a review. Artif. Intell. Rev. 55, 1947\u20131999 (2022).","journal-title":"Artif. Intell. Rev."},{"key":"2400_CR157","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0140-6736(69)90766-1","volume":"294","author":"LF Prescott","year":"1969","unstructured":"Prescott, L. F. Pharmacokinetic drug interactions. Lancet 294, 1239\u20131243 (1969).","journal-title":"Lancet"},{"key":"2400_CR158","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","volume":"50","author":"K Ito","year":"1998","unstructured":"Ito, K. et al. Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol. Rev. 50, 387\u2013411 (1998).","journal-title":"Pharmacol. Rev."},{"key":"2400_CR159","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Van De Waterbeemd","year":"2003","unstructured":"Van De Waterbeemd, H. & Gifford, E. ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2, 192\u2013204 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR160","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/90761","volume":"19","author":"J Hodgson","year":"2001","unstructured":"Hodgson, J. ADMET\u2014turning chemicals into drugs. Nat. Biotechnol. 19, 722\u2013726 (2001).","journal-title":"Nat. Biotechnol."},{"key":"2400_CR161","doi-asserted-by":"publisher","first-page":"108271","DOI":"10.1016\/j.pharmthera.2022.108271","volume":"238","author":"F Storelli","year":"2022","unstructured":"Storelli, F. et al. The next frontier in ADME science: predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans. Pharmacol. Ther. 238, 108271 (2022).","journal-title":"Pharmacol. Ther."},{"key":"2400_CR162","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1017\/S0033583515000190","volume":"48","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. In silico ADME\/T modelling for rational drug design. Q. Rev. Biophys. 48, 488\u2013515 (2015).","journal-title":"Q. Rev. Biophys."},{"key":"2400_CR163","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2009.88","volume":"23","author":"JE Cortes","year":"2009","unstructured":"Cortes, J. E. et al. Pharmacokinetic\/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia. Leukemia 23, 1537\u20131544 (2009).","journal-title":"Leukemia"},{"key":"2400_CR164","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2165\/00003495-199651020-00007","volume":"51","author":"B Fulton","year":"1996","unstructured":"Fulton, B. & Markham, A. Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51, 278\u2013298 (1996).","journal-title":"Drugs"},{"key":"2400_CR165","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkae254","volume":"52","author":"Y Myung","year":"2024","unstructured":"Myung, Y., de S\u00e1, A. G. C. & Ascher, D. B. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res. 52, W469\u2013W475 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR166","doi-asserted-by":"publisher","first-page":"19722","DOI":"10.1021\/acsnano.2c07312","volume":"16","author":"Z Lin","year":"2022","unstructured":"Lin, Z. et al. Integration of in vitro and in vivo models to predict cellular and tissue dosimetry of nanomaterials using physiologically based pharmacokinetic modeling. ACS Nano 16, 19722\u201319754 (2022).","journal-title":"ACS Nano"},{"key":"2400_CR167","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1289\/ehp.94102s1137","volume":"102","author":"D Krewski","year":"1994","unstructured":"Krewski, D. et al. Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment. Environ. Health Perspect. 102, 37\u201350 (1994).","journal-title":"Environ. Health Perspect."},{"key":"2400_CR168","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jconrel.2022.11.014","volume":"352","author":"R Ota","year":"2022","unstructured":"Ota, R. & Yamashita, F. Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics. J. Control. Release 352, 961\u2013969 (2022).","journal-title":"J. Control. Release"},{"key":"2400_CR169","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa267","volume":"22","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Computational drug repositioning based on multi-similarities bilinear matrix factorization. Brief. Bioinform. 22, bbaa267 (2021).","journal-title":"Brief. Bioinform."},{"key":"2400_CR170","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2165\/11593990-000000000-00000","volume":"71","author":"R Ogawa","year":"2011","unstructured":"Ogawa, R. & Echizen, H. Clinically significant drug interactions with antacids: an update. Drugs 71, 1839\u20131864 (2011).","journal-title":"Drugs"},{"key":"2400_CR171","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","volume":"57","author":"PN Maton","year":"1999","unstructured":"Maton, P. N. & Burton, M. E. Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs 57, 855\u2013870 (1999).","journal-title":"Drugs"},{"key":"2400_CR172","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1128\/AAC.6.4.437","volume":"6","author":"RG Dacey","year":"1974","unstructured":"Dacey, R. G. & Sande, M. A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6, 437\u2013441 (1974).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2400_CR173","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1056\/NEJM197908233010803","volume":"301","author":"W Doering","year":"1979","unstructured":"Doering, W. Quinidine-digoxin interaction: pharmacokinetics, underlying mechanism and clinical implications. N. Engl. J. Med. 301, 400\u2013404 (1979).","journal-title":"N. Engl. J. Med."},{"key":"2400_CR174","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM197905313002202","volume":"300","author":"WD Hager","year":"1979","unstructured":"Hager, W. D. et al. Digoxin-quinidine interaction: pharmacokinetic evaluation. N. Engl. J. Med. 300, 1238\u20131241 (1979).","journal-title":"N. Engl. J. Med."},{"key":"2400_CR175","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/00003495-198224030-00003","volume":"24","author":"JrJT Bigger","year":"1982","unstructured":"Bigger, J.rJ. T. & Leahey, J.rE. B. Quinidine and digoxin: an important interaction. Drugs 24, 229\u2013239 (1982).","journal-title":"Drugs"},{"key":"2400_CR176","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1161\/01.CIR.66.6.1277","volume":"66","author":"PE Fenster","year":"1982","unstructured":"Fenster, P. E. et al. Digoxin-quinidine interaction in patients with chronic renal failure. Circulation 66, 1277\u20131280 (1982).","journal-title":"Circulation"},{"key":"2400_CR177","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7326\/0003-4819-93-5-698","volume":"93","author":"PE FENSTER","year":"1980","unstructured":"FENSTER, P. E. et al. Digitoxin-quinidine interaction: pharmacokinetic evaluation. Ann. Intern. Med. 93, 698\u2013701 (1980).","journal-title":"Ann. Intern. Med."},{"key":"2400_CR178","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/bmj.284.6312.291","volume":"284","author":"CF George","year":"1982","unstructured":"George, C. F. Interactions with digoxin: more problems. Br. Med. J. 284, 291 (1982).","journal-title":"Br. Med. J."},{"key":"2400_CR179","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1503\/cmaj.140950","volume":"187","author":"DQ Li","year":"2015","unstructured":"Li, D. Q. et al. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. CMAJ 187, 174\u2013180 (2015).","journal-title":"CMAJ"},{"key":"2400_CR180","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S0140-6736(73)92799-2","volume":"302","author":"S Kenwright","year":"1973","unstructured":"Kenwright, S. & Levi, A. J. Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications. Lancet 302, 1401\u20131405 (1973).","journal-title":"Lancet"},{"key":"2400_CR181","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/cpt196893345","volume":"9","author":"G Milo","year":"1968","unstructured":"Milo, G. & Schwartz, M. A. Apparent effect of probenecid on the distribution of penicillins in man. Clin. Pharmacol. Ther. 9, 345\u2013349 (1968).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR182","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1212\/WNL.26.11.1008","volume":"26","author":"N WALTERS","year":"1976","unstructured":"WALTERS, N. et al. Penicillin transport from cerebrospinal fluid. Neurology 26, 1008\u20131008 (1976).","journal-title":"Neurology"},{"key":"2400_CR183","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJM197708252970802","volume":"297","author":"JP Hieber","year":"1977","unstructured":"Hieber, J. P. & Nelson, J. D. A pharmacologic evaluation of penicillin in children with purulent meningitis. N. Engl. J. Med. 297, 410\u2013413 (1977).","journal-title":"N. Engl. J. Med."},{"key":"2400_CR184","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1093\/jac\/dkac200","volume":"77","author":"RC Wilson","year":"2022","unstructured":"Wilson, R. C. et al. Addition of probenecid to oral \u03b2-lactam antibiotics: a systematic review and meta-analysis. J. Antimicrob. Chemother. 77, 2364\u20132372 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"2400_CR185","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/ph16071031","volume":"16","author":"L Dobrek","year":"2023","unstructured":"Dobrek, L. Lower urinary tract disorders as adverse drug reactions\u2014a literature review. Pharmaceuticals 16, 1031 (2023).","journal-title":"Pharmaceuticals"},{"key":"2400_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","volume":"106","author":"DM Jonker","year":"2005","unstructured":"Jonker, D. M. et al. Towards a mechanism-based analysis of pharmacodynamic drug\u2013drug interactions in vivo. Pharmacol. Ther. 106, 1\u201318 (2005).","journal-title":"Pharmacol. Ther."},{"key":"2400_CR187","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2165\/00003495-198529010-00002","volume":"29","author":"EM Sorkin","year":"1985","unstructured":"Sorkin, E. M. & Heel, R. C. Terfenadine: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29, 34\u201356 (1985).","journal-title":"Drugs"},{"key":"2400_CR188","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/014107689408701109","volume":"87","author":"SH Jackson","year":"1994","unstructured":"Jackson, S. H. Pharmacodynamics in the elderly. J. R. Soc. Med. 87, 5 (1994).","journal-title":"J. R. Soc. Med."},{"key":"2400_CR189","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/cpt.1434","volume":"105","author":"J Niu","year":"2019","unstructured":"Niu, J., Straubinger, R. M. & Mager, D. E. Pharmacodynamic drug\u2013drug interactions. Clin. Pharmacol. Ther. 105, 1395\u20131406 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR190","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1056\/NEJM195112202452503","volume":"245","author":"E Jawetz","year":"1951","unstructured":"Jawetz, E., Gunnison, J. B. & Speck, R. S. Antibiotic synergism and antagonism. N. Engl. J. Med. 245, 966\u2013968 (1951).","journal-title":"N. Engl. J. Med."},{"key":"2400_CR191","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.amjcard.2020.12.020","volume":"144","author":"PR Sinnaeve","year":"2021","unstructured":"Sinnaeve, P. R. & Adriaenssens, T. Dual antiplatelet therapy de-escalation strategies. Am. J. Cardiol. 144, S23\u2013S31 (2021).","journal-title":"Am. J. Cardiol."},{"key":"2400_CR192","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0031-6997(25)07161-3","volume":"19","author":"WR Martin","year":"1967","unstructured":"Martin, W. R. Opioid antagonists. Pharmacol. Rev. 19, 463\u2013521 (1967).","journal-title":"Pharmacol. Rev."},{"key":"2400_CR193","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/272826a0","volume":"272","author":"JD Levine","year":"1978","unstructured":"Levine, J. D. et al. The narcotic antagonist naloxone enhances clinical pain. Nature 272, 826\u2013827 (1978).","journal-title":"Nature"},{"key":"2400_CR194","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7326\/0003-4819-85-6-765","volume":"85","author":"WR MARTIN","year":"1976","unstructured":"MARTIN, W. R. Drugs five years later: naloxone. Ann. Intern. Med. 85, 765\u2013768 (1976).","journal-title":"Ann. Intern. Med."},{"key":"2400_CR195","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/263609a0","volume":"263","author":"WA Klee","year":"1976","unstructured":"Klee, W. A. & NIRENBERG, M. Mode of action of endogenous opiate peptides. Nature 263, 609\u2013612 (1976).","journal-title":"Nature"},{"key":"2400_CR196","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrd3673","volume":"11","author":"BP Roques","year":"2012","unstructured":"Roques, B. P., Fourni\u00e9-Zaluski, M. C. & Wurm, M. Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat. Rev. Drug Discov. 11, 292\u2013310 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2400_CR197","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell, P. M. et al. Effects of \u03b2 blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 9, 469\u2013480 (2010).","journal-title":"Lancet Neurol."},{"key":"2400_CR198","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","volume":"349","author":"H Jick","year":"1997","unstructured":"Jick, H. et al. Calcium-channel blockers and risk of cancer. Lancet 349, 525\u2013528 (1997).","journal-title":"Lancet"},{"key":"2400_CR199","doi-asserted-by":"publisher","first-page":"27S","DOI":"10.1111\/j.1365-2125.1987.tb03120.x","volume":"23","author":"AF Lant","year":"1987","unstructured":"Lant, A. F. Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions-parallels and contrasts. Br. J. Clin. Pharmacol. 23, 27S\u201341S (1987).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2400_CR200","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1751-7176.2011.00511.x","volume":"13","author":"M Epstein","year":"2011","unstructured":"Epstein, M. & Calhoun, D. A. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J. Clin. Hypertens. 13, 644 (2011).","journal-title":"J. Clin. Hypertens."},{"key":"2400_CR201","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1378\/chest.69.6.743","volume":"69","author":"H Thadepalli","year":"1976","unstructured":"Thadepalli, H., Niden, A. H. & Huang, J. T. Treatment of anaerobic pulmonary infections: Carbenicillin compared to clindamycin and gentamicin. Chest 69, 743\u2013746 (1976).","journal-title":"Chest"},{"key":"2400_CR202","doi-asserted-by":"publisher","first-page":"584","DOI":"10.7326\/0003-4819-81-5-584","volume":"81","author":"RM KLUGE","year":"1974","unstructured":"KLUGE, R. M. et al. The carbenicillin-gentamicin combination against Pseudomonas aeruginosa: correlation of effect with gentamicin sensitivity. Ann. Intern. Med. 81, 584\u2013587 (1974).","journal-title":"Ann. Intern. Med."},{"key":"2400_CR203","first-page":"919","volume":"105","author":"K Yuce","year":"1971","unstructured":"Yuce, K. & Van Rooyen, C. E. Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection. Can. Med. Assoc. J. 105, 919 (1971).","journal-title":"Can. Med. Assoc. J."},{"key":"2400_CR204","doi-asserted-by":"publisher","first-page":"13400","DOI":"10.1021\/ja803349j","volume":"130","author":"I Staub","year":"2008","unstructured":"Staub, I. & Sieber, S. A. \u03b2-Lactams as selective chemical probes for the in vivo labeling of bacterial enzymes involved in cell wall biosynthesis, antibiotic resistance, and virulence. J. Am. Chem. Soc. 130, 13400\u201313409 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"2400_CR205","doi-asserted-by":"crossref","unstructured":"Butler, K. et al. Carbenicillin: chemistry and mode of action. J. Infect. Dis S1\u2013S8 (1970).","DOI":"10.1093\/infdis\/122.Supplement_1.S1"},{"key":"2400_CR206","doi-asserted-by":"crossref","unstructured":"Yoshizawa S., Fourmy D. & Puglisi J. D. Structural origins of gentamicin antibiotic action. EMBO J. 17, 6437\u20136448 (1998).","DOI":"10.1093\/emboj\/17.22.6437"},{"key":"2400_CR207","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/35030019","volume":"407","author":"AP Carter","year":"2000","unstructured":"Carter, A. P. et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407, 340\u2013348 (2000).","journal-title":"Nature"},{"key":"2400_CR208","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1093\/infdis\/124.Supplement_1.S46","volume":"124","author":"VT Andriole","year":"1971","unstructured":"Andriole, V. T. Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J. Infect. Dis. 124, S46\u2013S55 (1971).","journal-title":"J. Infect. Dis."},{"key":"2400_CR209","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-73-2-173","volume":"73","author":"TA HOFFMAN","year":"1970","unstructured":"HOFFMAN, T. A., CESTERO, R. & BULLOCK, W. E. Pharmacodynamics of carbenicillin in hepatic and renal failure. Ann. Intern. Med. 73, 173\u2013178 (1970).","journal-title":"Ann. Intern. Med."},{"key":"2400_CR210","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(05)79447-2","volume":"351","author":"F El Bakri","year":"1998","unstructured":"El Bakri, F. et al. Ototoxicity induced by once-daily gentamicin. Lancet 351, 1407\u20131408 (1998).","journal-title":"Lancet"},{"key":"2400_CR211","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(05)79557-X","volume":"352","author":"N Modi","year":"1998","unstructured":"Modi, N. et al. Gentamicin concentration and toxicity. Lancet 352, 70 (1998).","journal-title":"Lancet"},{"key":"2400_CR212","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0163-4453(80)92816-9","volume":"2","author":"PE Lianou","year":"1980","unstructured":"Lianou, P. E. et al. Increased adherence to human epithelial cells of resistant Pseudomonas aeruginosa strains. J. Infect. 2, 354\u2013359 (1980).","journal-title":"J. Infect."},{"key":"2400_CR213","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(71)92152-0","volume":"298","author":"P Noone","year":"1971","unstructured":"Noone, P. & Pattison, J. R. Therapeutic implications of interaction of gentamicin and penicillins. Lancet 298, 575\u2013578 (1971).","journal-title":"Lancet"},{"key":"2400_CR214","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1503\/cmaj.120951","volume":"185","author":"DG Bailey","year":"2013","unstructured":"Bailey, D. G., Dresser, G. & Arnold, J. M. O. Grapefruit\u2013medication interactions: forbidden fruit or avoidable consequences?. J. CMAJ 185, 309\u2013316 (2013).","journal-title":"J. CMAJ"},{"key":"2400_CR215","first-page":"129","volume":"25","author":"LQ Guo","year":"2004","unstructured":"Guo, L. Q. & Yamazoe, Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol. Sin. 25, 129\u2013136 (2004).","journal-title":"Acta Pharmacol. Sin."},{"key":"2400_CR216","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0009-9236(95)90032-2","volume":"57","author":"MP Ducharme","year":"1995","unstructured":"Ducharme, M. P., Warbasse, L. H. & Edwards, D. J. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther. 57, 485\u2013491 (1995).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR217","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1067\/mcp.2000.110774","volume":"68","author":"DG Bailey","year":"2000","unstructured":"Bailey, D. G. et al. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin. Pharmacol. Ther. 68, 468\u2013477 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR218","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF00266354","volume":"42","author":"B Edgar","year":"1992","unstructured":"Edgar, B. et al. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine\u2014and its potential clinical relevance. Eur. J. Clin. Pharmacol. 42, 313\u2013317 (1992).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2400_CR219","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1067\/mcp.2001.113185","volume":"69","author":"S Malhotra","year":"2001","unstructured":"Malhotra, S. et al. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin. Pharmacol. Ther. 69, 14\u201323 (2001).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR220","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9236(03)00051-1","volume":"73","author":"DG Bailey","year":"2003","unstructured":"Bailey, D. G., Dresser, G. K. & Bend, J. R. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin. Pharmacol. Ther. 73, 529\u2013537 (2003).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2400_CR221","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/138920007781368917","volume":"8","author":"LQ Guo","year":"2007","unstructured":"Guo, L. Q. et al. Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine. Curr. drug Metab. 8, 623\u2013630 (2007).","journal-title":"Curr. drug Metab."},{"key":"2400_CR222","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2125.1998.00764.x","volume":"46","author":"DG Bailey","year":"1998","unstructured":"Bailey, D. G. et al. Grapefruit juice\u2013drug interactions. Br. J. Clin. Pharmacol. 46, 101\u2013110 (1998).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2400_CR223","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00192360","volume":"49","author":"J Lundahl","year":"1995","unstructured":"Lundahl, J. et al. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur. J. Clin. Pharmacol. 49, 61\u201367 (1995).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2400_CR224","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00228-003-0684-1","volume":"59","author":"L Gu\u00e9don-Moreau","year":"2003","unstructured":"Gu\u00e9don-Moreau, L. et al. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur. J. Clin. Pharmacol. 59, 689\u2013695 (2003).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2400_CR225","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaip.2020.08.002","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles, A. D., Banerji, A. & Castells, M. Practical guidance for the evaluation and management of drug hypersensitivity: general concepts. J. Allergy Clin. Immunol. Pract. 8, S3\u2013S15 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2400_CR226","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/lt.20606","volume":"11","author":"PJ Thuluvath","year":"2005","unstructured":"Thuluvath, P. J. When is diabetes mellitus a relative or absolute contraindication to liver transplantation?. Liver Transplant. 11, S25\u2013S29 (2005).","journal-title":"Liver Transplant."},{"key":"2400_CR227","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1093\/pm\/pnaa023","volume":"21","author":"M Boudier-Rev\u00e9ret","year":"2020","unstructured":"Boudier-Rev\u00e9ret, M., Gour-Proven\u00e7al, G. & Chang, M. C. Everything is relative,\u201d maybe even absolute contraindications. Pain. Med. 21, 3244\u20133245 (2020).","journal-title":"Pain. Med."},{"key":"2400_CR228","first-page":"39576","volume":"10","author":"AN Edinoff","year":"2022","unstructured":"Edinoff, A. N. et al. Clinically relevant drug interactions with monoamine oxidase inhibitors. J. Health Psychol. Res. 10, 39576 (2022).","journal-title":"J. Health Psychol. Res."},{"key":"2400_CR229","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1060028014561474","volume":"49","author":"LA Fraser","year":"2015","unstructured":"Fraser, L. A. et al. Calcium channel blocker\u2013clarithromycin drug interaction did not increase the risk of nonvertebral fracture: a population-based study. Ann. Pharmacother. 49, 185\u2013188 (2015).","journal-title":"Ann. Pharmacother."},{"key":"2400_CR230","doi-asserted-by":"publisher","unstructured":"Ying, Z. et al. Gnnexplainer: Generating explanations for graph neural networks. Advances in neural information processing systems. 32. https:\/\/doi.org\/10.48550\/arXiv.1903.03894 (2019).","DOI":"10.48550\/arXiv.1903.03894"},{"key":"2400_CR231","doi-asserted-by":"crossref","unstructured":"Uddin, S. H. et al. Interpretable Drug Interaction Forecasting: Leveraging Graph Neural Networks with Explainable Artificial Intelligence. In International Conference on Generative Artificial Intelligence, Cryptography, and Predictive Analytics, 59\u221272 (Springer Nature, Singapore, 2024).","DOI":"10.1007\/978-981-97-9132-3_5"},{"key":"2400_CR232","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.2847","volume":"11","author":"R Li","year":"2025","unstructured":"Li, R. et al. Towards interpretable drug interaction prediction via dual-stage attention and Bayesian calibration with active learning. PeerJ Comput. Sci. 11, e2847 (2025).","journal-title":"PeerJ Comput. Sci."},{"key":"2400_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.122500","volume":"240","author":"H Yu","year":"2024","unstructured":"Yu, H. et al. GGI-DDI: identification for key molecular substructures by granule learning to interpret predicted drug-drug interactions. Expert Syst. Appl. 240, 122500 (2024).","journal-title":"Expert Syst. Appl."},{"key":"2400_CR234","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43856-024-00486-y","volume":"4","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Yang, Z. & Yao, Q. Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning. Commun. Med. 4, 59 (2024).","journal-title":"Commun. Med."},{"key":"2400_CR235","doi-asserted-by":"crossref","unstructured":"Lin, X. et al. Interpretable multi-view attention network for drug-drug interaction prediction. In Proc. IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 422\u2013427 (IEEE, 2023).","DOI":"10.1109\/BIBM58861.2023.10385757"},{"key":"2400_CR236","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100\u2013D1107 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR237","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR238","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945\u2013D954 (2017).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR239","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ng0407-426","volume":"39","author":"RB Altman","year":"2007","unstructured":"Altman, R. B. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat. Genet. 39, 426\u2013426 (2007).","journal-title":"Nat. Genet."},{"key":"2400_CR240","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/nar\/30.1.163","volume":"30","author":"M Hewett","year":"2002","unstructured":"Hewett, M. et al. PharmGKB: the pharmacogenetics knowledge base. Nucleic Acids Res. 30, 163\u2013165 (2002).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR241","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.clpt.6100048","volume":"81","author":"AE Hodge","year":"2007","unstructured":"Hodge, A.E. et al. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge. J. Clin. Pharmacol. Ther. 81, 21\u201324 (2007).","journal-title":"J. Clin. Pharmacol. Ther."},{"key":"2400_CR242","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn, M. et al. The SIDER database of drugs and side effects. Nucleic acids Res. 44, D1075\u2013D1079 (2016).","journal-title":"Nucleic acids Res."},{"key":"2400_CR243","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013D961 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR244","doi-asserted-by":"publisher","first-page":"W43","DOI":"10.1093\/nar\/gkz337","volume":"47","author":"B Zagidullin","year":"2019","unstructured":"Zagidullin, B. et al. DrugComb: an integrative cancer drug combination data portal. Nucleic Acids Res. 47, W43\u2013W51 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR245","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkab438","volume":"49","author":"S Zheng","year":"2021","unstructured":"Zheng, S. et al. DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal. Nucleic Acids Res. 49, W174\u2013W184 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR246","first-page":"D871","volume":"48","author":"H Liu","year":"2020","unstructured":"Liu, H. et al. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic Acids Res. 48, D871\u2013D881 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR247","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1093\/nar\/gkab836","volume":"49","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. Correction to \u2018DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic Acids Res. 49, 10801\u201310802 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2400_CR248","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae328","volume":"25","author":"A Ianevski","year":"2024","unstructured":"Ianevski, A. et al. RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono-and combination therapies. Brief. Bioinform. 25, bbae328 (2024).","journal-title":"Brief. Bioinform."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02400-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:07:02Z","timestamp":1772543222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02400-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":248,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02400-3","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}